|
|
Volumn 9, Issue 3, 1998, Pages 587-601
|
|
Therapeutic and symptomatic treatment of multiple sclerosis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMANTADINE;
AZATHIOPRINE;
BETA1A INTERFERON;
BISACODYL;
CANNABIS;
CARBAMAZEPINE;
CLADRIBINE;
CLONAZEPAM;
CLONIDINE;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
DANTROLENE;
DESMOPRESSIN;
DIAZEPAM;
GABAPENTIN;
GLATIRAMER;
GLYCINE;
HYDROXYZINE;
INTERFERON BETA SERINE;
METHYLPREDNISOLONE;
MYELIN;
PHENOTHIAZINE DERIVATIVE;
PHENYTOIN;
PROGABIDE;
ROQUINIMEX;
SENOKOT;
STEROID;
TACROLIMUS;
THALIDOMIDE;
TIZANIDINE;
UNINDEXED DRUG;
ALOPECIA;
BLADDER DYSFUNCTION;
BONE MARROW SUPPRESSION;
DRUG RESPONSE;
ELECTROLYTE DISTURBANCE;
GASTROINTESTINAL DISEASE;
HUMAN;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
MOTOR DYSFUNCTION;
MULTIPLE SCLEROSIS;
MUSCULOSKELETAL DISEASE;
NEPHROTOXICITY;
PARESTHESIA;
PRIORITY JOURNAL;
REVIEW;
SPASTICITY;
SYMPTOMATOLOGY;
TREATMENT INDICATION;
|
|
EID: 0031722265
PISSN: 10479651
EISSN: None
Source Type: Journal
DOI: 10.1016/s1047-9651(18)30251-1 Document Type: Review |
|
Times cited : (10)
|
|
References (105)
|
